What is a stock summary page? Click here for an overview.
Business Description
Athira Pharma Inc
NAICS : 541714
SIC : 2833
ISIN : US04746L1044
Share Class Description:
ATHA: Ordinary SharesDescription
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 42.13 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -18.9 | |||||
| 3-Year EPS without NRI Growth Rate | -17.4 | |||||
| 3-Year FCF Growth Rate | -27.8 | |||||
| 3-Year Book Growth Rate | -48.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 29.25 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.31 | |||||
| 9-Day RSI | 30.74 | |||||
| 14-Day RSI | 31.63 | |||||
| 3-1 Month Momentum % | -34.35 | |||||
| 6-1 Month Momentum % | -11.63 | |||||
| 12-1 Month Momentum % | -84.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.18 | |||||
| Quick Ratio | 4.18 | |||||
| Cash Ratio | 3.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | 3.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -114.67 | |||||
| ROA % | -88.13 | |||||
| ROIC % | -1155.61 | |||||
| 3-Year ROIIC % | 62.95 | |||||
| ROC (Joel Greenblatt) % | -2514.16 | |||||
| ROCE % | -113.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.23 | |||||
| Price-to-Tangible-Book | 0.23 | |||||
| EV-to-EBIT | 0.4 | |||||
| EV-to-EBITDA | 0.41 | |||||
| EV-to-FCF | 0.4 | |||||
| Price-to-Net-Current-Asset-Value | 0.25 | |||||
| Price-to-Net-Cash | 0.27 | |||||
| Earnings Yield (Greenblatt) % | 250 | |||||
| FCF Yield % | -957.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ATHA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Athira Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.53 | ||
| Beta | 2.93 | ||
| 3-Year Sharpe Ratio | -0.28 | ||
| 3-Year Sortino Ratio | -0.38 | ||
| Volatility % | 121.2 | ||
| 14-Day RSI | 31.63 | ||
| 14-Day ATR ($) | 0.036767 | ||
| 20-Day SMA ($) | 0.320435 | ||
| 12-1 Month Momentum % | -84.95 | ||
| 52-Week Range ($) | 0.251 - 3.67 | ||
| Shares Outstanding (Mil) | 39.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Athira Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Athira Pharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Athira Pharma Inc Frequently Asked Questions
What is Athira Pharma Inc(ATHA)'s stock price today?
The current price of ATHA is $0.26. The 52 week high of ATHA is $3.67 and 52 week low is $0.25.
When is next earnings date of Athira Pharma Inc(ATHA)?
The next earnings date of Athira Pharma Inc(ATHA) is 2025-05-15 Est..
Does Athira Pharma Inc(ATHA) pay dividends? If so, how much?
Athira Pharma Inc(ATHA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers